微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 12.49% | -10.73% | 6.09% | 50/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 11.77% | -20.11% | 0.17% | 51/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 11.75% | -15.04% | -13.74% | 49/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 13.62% | -21.54% | -2.62% | 50/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 13.99% | -23.19% | -5.05% | 49/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 14.73% | -21.74% | 6.53% | 50/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 13.83% | -23.28% | -20.34% | 49/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 17.36% | -6.14% | -4.67% | 50/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 18.21% | -0.87% | -3.26% | 48/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 18.83% | -10.5% | 4.42% | 48/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 18.03% | -32.59% | -2.53% | 48/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 18.5% | 45.92% | 0.68% | 49/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 18.37% | 29.43% | -12.66% | 47/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 21.03% | 40.7% | -21.35% | 49/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 26.74% | 75.78% | 110.98% | 42/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 12.68% | -20.21% | -10.7% | 50/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 14.19% | -22.18% | -5.05% | 45/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 14.95% | -19.26% | -1.74% | 46/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 15.21% | -29.16% | -4.23% | 37/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 15.89% | 6.78% | -12.91% | 47/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 18.24% | 29.2% | -1.49% | 35/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 18.52% | 39.42% | -13.79% | 43/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 21.48% | 60.02% | 44.37% | 32/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 14.88% | 23.99% | 5.38% | 44/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 14.12% | 13.61% | 6.3% | 29/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 13.28% | 11.7% | -1.05% | 28/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 13.42% | 25.61% | 11.86% | 25/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 12% | -20.13% | -3.44% | 39/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 12.43% | -21.74% | 4.5% | 25/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 11.89% | -20.95% | 11.28% | 26/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 10.69% | -13.82% | -28.87% | 23/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 15.02% | -28.1% | -5.38% | 35/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 15.88% | -27.92% | 5.55% | 22/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 15.04% | -31.62% | 21.32% | 26/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 12.4% | -42.01% | -40.66% | 21/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 20.89% | 11.36% | -5.14% | 28/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 22.03% | 12.3% | 0.13% | 20/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 22% | 8.68% | 2.89% | 21/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 21.38% | -7.96% | 13.95% | 18/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |